These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5127091)

  • 1. Significance of vehicle composition. II. Prediction of optimal vehicle composition.
    Ostrenga J; Steinmetz C; Poulsen B; Yett S
    J Pharm Sci; 1971 Aug; 60(8):1180-3. PubMed ID: 5127091
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles.
    Coldman MF; Poulsen BJ; Higuchi T
    J Pharm Sci; 1969 Sep; 58(9):1098-102. PubMed ID: 5346073
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial properties of a propylene glycol based topical therapeutic agent.
    Olitzky I
    J Pharm Sci; 1965 May; 54(5):787-8. PubMed ID: 5845896
    [No Abstract]   [Full Text] [Related]  

  • 6. SCALP DERMATOSES. TREATMENT WITH FLUOCINOLONE ACETONIDE IN PROPYLENE GLYCOL.
    LUBOWE II
    Skin (Los Angeles); 1964 Sep; 3():267-9. PubMed ID: 14202034
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and evaluation of ointment and cream vehicles for a new topical steroid, fluclorolone acetonide.
    Malone T; Haleblian JK; Poulsen BJ; Burdick KH
    Br J Dermatol; 1974 Feb; 90(2):187-95. PubMed ID: 4819137
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of plasma cortisol in patients treated with fluocinonide cream with either open or occlusive application.
    Pozzo G; Prandini BD
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):40-2. PubMed ID: 5291632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of vehicle composition on the liberation and percutaneous penetration of corticosteroids].
    Moës-Henschel V; Jaminet F
    J Pharm Belg; 1975; 30(4):390-404. PubMed ID: 1206464
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluocinonide in FAPG base: a review of its therapeutic efficacy in inflammatory dermatoses.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1974; 7(5):337-43. PubMed ID: 4604483
    [No Abstract]   [Full Text] [Related]  

  • 11. [Penetration kinetics of topical steroids].
    Tronnier H
    Arch Klin Exp Dermatol; 1970; 237(3):769-73. PubMed ID: 5523569
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of formulation on the clinical response to topical fluocinolone acetonide.
    Portnoy B
    Br J Dermatol; 1965 Nov; 77(11):579-81. PubMed ID: 5853252
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of vehicle dielectric properties on rectal absorption of acetaminophen.
    Shangraw RF; Walkling WD
    J Pharm Sci; 1971 Apr; 60(4):600-2. PubMed ID: 5128372
    [No Abstract]   [Full Text] [Related]  

  • 14. Propylene glycol gel vehicles.
    Lorenzetti OJ
    Cutis; 1979 Jun; 23(6):747, 750. PubMed ID: 467096
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of 0.01 per cent solution of fluocinolone acetonide in propylene glycol].
    Aceves Ortega R
    Medicina (Mex); 1965 Apr; 45(962):171-6. PubMed ID: 5837268
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical corticosteroids--an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity.
    Reid J; Brookes DB
    Br J Dermatol; 1968 May; 80(5):328-36. PubMed ID: 4873078
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of vehicles in the percutaneous absorption of corticosteroids. An experimental and clinical study.
    Sarkany I; Hadgraft JW; Caron GA; Barrett CW
    Br J Dermatol; 1965 Nov; 77(11):569-75. PubMed ID: 5322445
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of topical vehicle composition on the in vitro release of fluocinolone acetonide and its acetate ester.
    Poulsen BJ; Young E; Coquilla V; Katz M
    J Pharm Sci; 1968 Jun; 57(6):928-33. PubMed ID: 5671339
    [No Abstract]   [Full Text] [Related]  

  • 19. [Further observations with fluocinolone acetonide in local administration].
    Gatti JC; Cardama JE; Avila JJ; Carnevale Benino de Gar
    Prensa Med Argent; 1966 Sep; 53(35):1919-20. PubMed ID: 6011708
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation and prediction of mass transport across membranes. II. Influence of vehicle polarity on flux from solutions and suspensions.
    Yalkowsky SH; Flynn GL
    J Pharm Sci; 1974 Aug; 63(8):1276-80. PubMed ID: 4851195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.